<- Go Home

Allergan plc

Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide.

Market Cap

$63.7B

Volume

3.3M

Cash and Equivalents

$999.5M

EBITDA

$7.2B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$13.5B

Profit Margin

84.13%

52 Week High

$202.22

52 Week Low

$114.27

Dividend

N/A

Price / Book Value

1.10

Price / Earnings

-25.50

Price / Tangible Book Value

-3.26

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

$1.1B

Return on Equity

-4.15%

Return on Assets

0.74

Cash and Short Term Investments

$2.6B

Debt

$20.1B

Equity

$58.0B

Revenue

$16.1B

Unlevered FCF

$6.9B

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches